ABABioBlurb

Official Twitter handle for the American Bar Association SciTech BioBlurb! Follow for updates on Biotech Law, Policy, and Markets!

[ABABioBlurb @ABABioBlurb]

IRB Responsibilities for Reviewing the Qualifications of Investigators, Adequacy of Research Sites, and the Determination of Whether an IND/IDE is Needed https://t.co/45fLaymPei

[ABABioBlurb @ABABioBlurb]

Developing Products for Rare Diseases & Conditions https://t.co/fL6ZrzJpIX

[ABABioBlurb @ABABioBlurb]

Drug Alerts and Statements https://t.co/GMkaYGPmfQ

[ABABioBlurb @ABABioBlurb]

FDA to Hold Public Hearing May 31 Regarding Cannabis https://t.co/SnmLl6bVpp

[ABABioBlurb @ABABioBlurb]

TeraPharm - 111111 - 10/09/2018 https://t.co/4zOJKWgoMN

[ABABioBlurb @ABABioBlurb]

SUPAC: Manufacturing Equipment Addendum https://t.co/3DHGpjcmYl

[ABABioBlurb @ABABioBlurb]

Botanical Drug Development: Guidance for Industry https://t.co/IkwtECaLpd

[ABABioBlurb @ABABioBlurb]

Comparability Protocols for Human Drugs and Biologics: Chemistry, Manufacturing, and Controls Information Guidance for Industry https://t.co/0BKH58YLfP

[ABABioBlurb @ABABioBlurb]

ANDAs: Stability Testing of Drug Substances and Products, Questions and Answers https://t.co/gnuUNyWoc0

[ABABioBlurb @ABABioBlurb]

Use of Liquids and/or Soft Foods as Vehicles for Drug Administration: General Considerations for Selection and In Vitro Methods for Product Quality Assessments https://t.co/PIqgJDcyYm

[ABABioBlurb @ABABioBlurb]

Assay Development and Validation for Immunogenicity Testing of Therapeutic Protein Products https://t.co/fsOrx1Gqwq

[ABABioBlurb @ABABioBlurb]

Completeness Assessments for Type II API DMFs Under GDUFA Guidance for Industry https://t.co/n6cdARon0j

[ABABioBlurb @ABABioBlurb]

Bispecific Antibody Development Programs Guidance for Industry https://t.co/1G2AmDbiW6

[ABABioBlurb @ABABioBlurb]

Development and Submission of Near Infrared Analytical Procedures https://t.co/fJp9MciRXF

[ABABioBlurb @ABABioBlurb]

Size, Shape, and Other Physical Attributes of Generic Tablets and Capsules https://t.co/sovzgB27nr

[ABABioBlurb @ABABioBlurb]

Regulatory Classification of Pharmaceutical Co-Crystals https://t.co/5e1TKXYU9r

[ABABioBlurb @ABABioBlurb]

Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) Drug Products--Quality Considerations https://t.co/ywKWV7mQ1o

[ABABioBlurb @ABABioBlurb]

Immunogenicity-Related Considerations for Low Molecular Weight Heparin Guidance for Industry https://t.co/UdmbiBmnUo

[ABABioBlurb @ABABioBlurb]

Liposome Drug Products: Chemistry, Manufacturing, and Controls; Human Pharmacokinetics and Bioavailability; and Labeling Documentation https://t.co/zNeBYEzzXc

[ABABioBlurb @ABABioBlurb]

Elemental Impurities in Drug Products Guidance for Industry https://t.co/DFW95etAVo